---
title: "Orient Biotech and its subsidiaries have obtained multiple medical device registration certificates"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/245049518.md"
description: "According to the Zhitong Finance APP, Orient Biotech announced that the company and its subsidiary Shanghai Wanzi Health Biotechnology Co., Ltd. recently obtained the following China Medical Device Registration Certificates (in vitro diagnostic reagents), with the product names as follows: Hepatitis B Virus Surface Antigen (HBsAg) Test Reagent (Colloidal Gold Method), Carbohydrate Antigen 50 Test Kit (Flow Fluorescence Luminance Method), Carbohydrate Antigen 242 Test Kit (Flow Fluorescence Luminance Method)"
datetime: "2025-06-18T08:50:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/245049518.md)
  - [en](https://longbridge.com/en/news/245049518.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/245049518.md)
generator: "portal-rs"
---

# Orient Biotech and its subsidiaries have obtained multiple medical device registration certificates

According to the Zhitong Finance APP, Orient Biotech (688298.SH) announced that the company and its subsidiary Shanghai Wanzi Jian Biotechnology Co., Ltd. recently obtained the following Chinese medical device registration certificates (in vitro diagnostic reagents), with the product names as follows: Hepatitis B virus surface antigen (HBsAg) detection reagent (colloidal gold method), carbohydrate antigen 50 detection reagent kit (flow fluorescence luminescence method), carbohydrate antigen 242 detection reagent kit (flow fluorescence luminescence method)

### Related Stocks

- [688298.CN](https://longbridge.com/en/quote/688298.CN.md)

## Related News & Research

- [Epinephrine injection recalled over potentially fatal health risks](https://longbridge.com/en/news/298065018.md)
- [Biohit says scientific review backs serum biomarker triage to target endoscopy for gastric cancer risk](https://longbridge.com/en/news/297887371.md)
- [08:04 ETKearney releases the Circular Fashion Index 2026](https://longbridge.com/en/news/297782637.md)
- [08:32 ETVitria Technology Named a Sample Vendor for Event Intelligence Solutions in Eight 2026 Gartner® Hype Cycle™ Reports](https://longbridge.com/en/news/297787056.md)
- [eGenesis Announces Clinical Update in Ongoing Expanded Access Study of EGEN-2784 in Patients with Kidney Failure](https://longbridge.com/en/news/297965488.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**